Historical Valuation
Ocugen Inc (OCGN) is now in the Fair zone, suggesting that its current forward PS ratio of 171.71 is considered Fairly compared with the five-year average of -27.19. The fair price of Ocugen Inc (OCGN) is between 0.22 to 2.97 according to relative valuation methord.
Relative Value
Fair Zone
0.22-2.97
Current Price：1.50
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Ocugen Inc (OCGN) has a current Price-to-Book (P/B) ratio of 121.99. Compared to its 3-year average P/B ratio of 25.66 , the current P/B ratio is approximately 375.44% higher. Relative to its 5-year average P/B ratio of 21.98, the current P/B ratio is about 455.04% higher. Ocugen Inc (OCGN) has a Forward Free Cash Flow (FCF) yield of approximately -12.42%. Compared to its 3-year average FCF yield of -31.18%, the current FCF yield is approximately -60.17% lower. Relative to its 5-year average FCF yield of -21.40% , the current FCF yield is about -41.96% lower.
P/B
Median3y
25.66
Median5y
21.98
FCF Yield
Median3y
-31.18
Median5y
-21.40
Competitors Valuation Multiple
AI Analysis for OCGN
The average P/S ratio for OCGN competitors is 34.46, providing a benchmark for relative valuation. Ocugen Inc Corp (OCGN.O) exhibits a P/S ratio of 171.71, which is 398.28% above the industry average. Given its robust revenue growth of 54.23%, this premium appears sustainable.
Performance Decomposition
AI Analysis for OCGN
1Y
3Y
5Y
Market capitalization of OCGN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of OCGN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is OCGN currently overvalued or undervalued?
Ocugen Inc (OCGN) is now in the Fair zone, suggesting that its current forward PS ratio of 171.71 is considered Fairly compared with the five-year average of -27.19. The fair price of Ocugen Inc (OCGN) is between 0.22 to 2.97 according to relative valuation methord.
What is Ocugen Inc (OCGN) fair value?
OCGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Ocugen Inc (OCGN) is between 0.22 to 2.97 according to relative valuation methord.
How does OCGN's valuation metrics compare to the industry average?
The average P/S ratio for OCGN's competitors is 34.46, providing a benchmark for relative valuation. Ocugen Inc Corp (OCGN) exhibits a P/S ratio of 171.71, which is 398.28% above the industry average. Given its robust revenue growth of 54.23%, this premium appears sustainable.
What is the current P/B ratio for Ocugen Inc (OCGN) as of Jan 12 2026?
As of Jan 12 2026, Ocugen Inc (OCGN) has a P/B ratio of 121.99. This indicates that the market values OCGN at 121.99 times its book value.
What is the current FCF Yield for Ocugen Inc (OCGN) as of Jan 12 2026?
As of Jan 12 2026, Ocugen Inc (OCGN) has a FCF Yield of -12.42%. This means that for every dollar of Ocugen Inc’s market capitalization, the company generates -12.42 cents in free cash flow.
What is the current Forward P/E ratio for Ocugen Inc (OCGN) as of Jan 12 2026?
As of Jan 12 2026, Ocugen Inc (OCGN) has a Forward P/E ratio of -5.98. This means the market is willing to pay $-5.98 for every dollar of Ocugen Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Ocugen Inc (OCGN) as of Jan 12 2026?
As of Jan 12 2026, Ocugen Inc (OCGN) has a Forward P/S ratio of 171.71. This means the market is valuing OCGN at $171.71 for every dollar of expected revenue over the next 12 months.